The p53 tumour suppressor protein has a crucial role in controlling cell cycle and apoptosis in human cells and its inactivation by selective point mutations is associated with human cancers. Here we show that overexpression of the human wild-type (wt) p53 in Saccharomyces cerevisiae completely inhibits yeast growth under minimal media conditions. In contrast, the R248W 'hot spot' p53 mutant (one of the most frequent p53 mutations encountered in human cancers) does not impair yeast growth. Moreover, we report, for the first time, that the human wt p53 induces yeast cell death with characteristic markers of apoptosis: exposure of phosphatidylserine and DNA strand cleavage as shown by Annexin V staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling assay, respectively. In addition, p53 also has an impact on the expression of yeast genes. Using differential display and Northern blot analysis, we demonstrated that human wt p53 expression in yeast leads to gene repression of thioredoxin (TRX1/ 2), a highly conserved multifunctional antioxidative and antiapoptotic protein family. Accordingly, we demonstrated that reactive oxygen species (ROS) are highly produced in p53 yeast induced cell death as shown by dihydrorhodamine 123 staining. These results suggest that the generation of ROS is a key event in p53 yeast induced cell death.
Introduction
The p53 tumour suppressor protein is a nuclear phosphoprotein that plays a crucial role in safeguarding genome integrity (Zambetti & Levine, 1993; Jacks & Weinberg, 1996; Prives & Hall, 1999) . This protein is maintained at a low level in cells under normal circumstances, but in response to various stresses (DNA damage, hypoxia, suboptimal growth conditions and oncogene activation), p53 is activated and it induces the expression of different target genes involved in cell cycle, DNA repair and apoptosis.
Mutations in the p53 tumour suppressor gene are found in 4 50% of human cancers (Beroud & Soussi, 2003) . The majority involves missense mutations rather than nonsense mutations or deletions (Sigal & Rotter, 2000) and localizes mostly in the DNA-binding domain (Levine et al., 1995; Hainaut et al., 1998) . The most frequent missense mutations associated with cancer target distinct 'hot spot' amino acid residues such as R248, R249 and R282 (Kato et al., 2003) .
The pioneering work of Scharer & Iggo (1992) showed that the mammalian p53 can function as a transcription factor in yeast. Thereafter, several groups found Saccharomyces cerevisiae to be a handy tool in studying the transcriptional activity of human p53 protein [wild-type (wt) and tumour-derived mutants] using the functional analysis of separated alleles in yeast (FASAY) (Flaman et al., 1995) . A yeast strain containing an integrated plasmid with the ADE2 ORF, as a reporter gene, under the control of the p53 responsive element was transformed with a p53-expressing plasmid. Consequently, yeast colonies containing wt p53 are white and colonies containing mutant p53 are red. This result implies that the p53 protein is relocated to the nucleus to induce the expression of reporter genes. Nevertheless, very few studies have investigated the direct effect of human p53 protein on the yeast host cell growth. Nigro et al. (1992) showed that yeast cells coexpressing p53 and CDC2H (a gene involved in cell cycle regulation) were partially arrested in G1. More recently, our group reported that under rich medium (RM) culture conditions, wt p53 expression caused a slight delay in growth in S. cerevisiae (Mokdad-Gargouri et al., 2001) .
In this work, we expressed p53, a key proapoptotic human gene in S. cerevisiae. We found that the expression of wt p53 was lethal for yeast cultured in a minimal medium (MM). In contrast, the hot spot p53 mutant R248W was completely inactive. We showed for the first time that the human wt p53 induces yeast cell death on MM. We also found that wt p53 expression in yeast affected the transcription of several yeast genes, among which we identified the thioredoxin TRX1/2, which were shown to be the major component of the thioredoxin yeast system and required for the detoxification of reactive oxygen species (ROS). In agreement with this finding, Dihydrorhodamine 123 (DHR 123) staining showed a strong ROS accumulation in p53 yeast expressing cells.
Materials and methods

Strains and media
The yeast strain used in all experiments was W303-1B (MATa ade2-1 ura3-1 his3-11,15 leu2-3112 trp1-1 can1-100). Yeast MM contained 0.67% yeast nitrogen base (Difco). Tryptophane, histidine, leucine and adenine were added to a concentration of 40, 20, 120 and 40 mg L À1 , respectively. RM contained 1% Bacto peptone and 1% yeast extract. Both MM and RM were supplemented with either 2% glucose or raffinose (for normal growth) or 2% galactose (for gene induction) as a carbon source. The growth kinetics were studied on liquid and solid media.
Plasmids
The yeast multicopy YepDP8-1 vector (provided by D. Pompon, C.G.M., CNRS-Gif Sur Yvette, France), named 'pDP' here, was used to express human p53 (wt and mutant form) under the control of the Gal10/Cyc1 galactose-inducible yeast promoter. This vector contains the 2 mm replication origin and the ura 3 marker (Cullin & Pompon, 1988) . Insertion of the wt p53 cDNA into this yeast expression vector has been described previously (Mokdad-Gargouri et al., 2001) . The R248W, 'hot spot' mutant cDNA was kindly provided by Prof. Ozturk (Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey). The plasmids were then transferred to S. cerevisiae according to standard protocols (Ito et al., 1983) . These constructions were verified by sequencing with the Big Dye R Terminator v3.1 cycle sequencing kit, using the ABI Prism 3100-Avant Genetic Analyzer (Applied Biosystems/Hitachi).
Protein extraction and Western blot
For Western blot, recombinant yeast strains were grown on MM that contained 2% glucose/raffinose until the OD reached 4 U mL À1 , and then 2% galactose was added as an inducer of the Gal10-cyc1 promoter to drive p53 expression. An appropriate volume (1 mL) of the culture was harvested by centrifugation; pellets were incubated on ice and suspended in 100 mL of lysis buffer (50 mM sodium phosphate, pH 7.4; 1 mM EDTA; and 5% glycerol). Acid-washed glass beads (size, 0.5 mm) were added, v/v, and vortexed for eight cycles of 30 s on ice. Protein lysates were separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto a polyvinylidene difluoride (PVDF) membrane. Immunodetection was carried out with the monoclonal antibody DO-1 (Santa Cruz Biotechnology) diluted at 1/1000, followed by an anti-mouse immunoglobulin antiserum conjugated to horseradish peroxidase (BioRad) and revealed by chemoluminescence using the ECL Plus kit (Amersham). 
Growth kinetics and cell viability
Differential display (DD) and Northern blot
DD is a reverse transcriptase-PCR-based technique used for determining differences in gene expression under two different conditions. RNA was extracted from yeast cells as described previously (Mokdad-Gargouri et al., 2001 ) and subjected to reverse transcription using various anchored downstream primers (oligodT 15 -VV, with V being one of three dNTPs G, C or A). Each cDNA was NaOH treated and subjected to PCR using various random primers of nine bases, in the presence of Taq buffer, 0.2 mM dNTP (with a 32 P dCTP), 2 mM MgCl 2 and 1 U Taq polymerase. Cycling was as follows: 50 cycles (30 s at 94 1C, 1 min at 42 1C and 1 min at 72 1C). PCR products were run on sequencing 6% polyacrylamide gel and autoradiographed.
Northern blots were performed as described previously (Mokdad-Gargouri et al., 2001) . The probe used corresponds to a fragment of the S. cerevisiae TRX2 gene that was isolated through DD techniques using the following oligonucleotides: AGCCAGCGAA and dT 15 AG as the upstream arbitrary 10mer and anchored oligo-dT primers, respectively.
Terminal deoxynucleotidyl transferasemediated dUTP nick end labelling (TUNEL) assay DNA strand breaks were detected by TUNEL with the In Situ Cell Death Detection kit-Fluorescein from Roche, essentially as described by Ribeiro et al. (2006) , with some modifications. Yeast cells were fixed with 3.7% (v/v) formaldehyde for 30 min at room temperature, washed three times with phosphate-buffered saline (PBS) and cell walls were digested with zymolyase 100T in lysis buffer (1 M sorbitol, 50 mM citric acid, 150 mM K 2 HPO 4 , 10 mM EDTA, 0.1% b-mercaptoethanol and 0.3 mg mL À1 zymolyase). Ten microlitres of the cell suspension was applied to a polylysine-coated slide and allowed to dry for 30 min at 37 1C. The slides were rinsed with PBS, incubated in permeabilization solution (0.1% triton X-100, 0.1% sodium citrate) for 2 min on ice and rinsed twice with PBS. For a positive control of the TUNEL assay, 30 U of DNAse I was applied to cells on microscope slides. The slides were placed in a humidified box for 1 h at 37 1C. They were then washed for 15 min in PBS twice. Slides were subsequently incubated with 10 mL of TUNEL reaction mixture for 60 min and finally rinsed three times with PBS. Observations were carried out using an LSMS 5 PASCAL confocal microscope (Carl Zeiss, Germany). Quantification of apoptotic cells by TUNEL staining was carried out by fluorescence-activated cell sorting (FACS) analysis on an EPICS s XL flow cytometer (Beckman Coulter). At least 15 000 cells were counted per run and experiments were reproduced three times.
Annexin V and propidium iodide (PI) staining
Exposed phosphatidylserine and internal PI staining were detected using the Annexin-V-FLUOS Staining Kit from Roche, essentially as described by Madeo et al. (1997) . Yeast cell walls were digested as described above for the TUNEL assay. Observations were carried out using an LSMS 5 PASCAL confocal microscope (Carl Zeiss).
ROS detection
ROS were detected with DHR 123 (Invitrogen) as described previously (Madeo et al., 1999) . Cells were viewed through a fluorescein isothiocyanate (FITC) channel after a 2-h incubation with DHR 123. Observations were carried out using an LSMS 5 PASCAL confocal microscope (Carl Zeiss).
Results
Human p53 expression in yeast cells
The human p53 cDNA sequence (wt) was inserted downstream of the Gal10/cyc1 inducible promoter on a high copy number and stable plasmid YepDP8-1 (pDP). The p53 insert contained only the ORF without the untranslated regions (UTRs), which may impair translation in yeast. Indeed, our group reported previously that the presence of 5 0 and 3 0 UTRs led to a low-level production of a truncated p53 and that the deletion of both UTRs improved the expression level of a full-length p53 protein (Mokdad-Gargouri et al., 2001) . The pDP/wt and pDP (negative control) were transferred into the W303-1B S. cerevisiae strain, giving rise to the respective recombinant yeast clones W303/pDP and W303/wt.
To study the effect of p53 protein on yeast growth, galactose was used as a carbon source as well as an inducer for p53 expression. W303/wt was grown on raffinose-containing MM, allowing the Gal10/Cyc1 promoter to be in a nonrepressed state. At the end of the exponential growth phase (OD reaching 4), galactose was added at different concentrations varying from 0% to 2%. As expected, the p53 protein was not detected in the absence of galactose (Fig.  1a) . A dose-dependent induction of p53 protein expression could be observed after the galactose addition (Fig. 1a) . A concentration of 2% galactose, largely sufficient for both p53 expression and yeast growth, was then chosen to follow the kinetics of p53 expression. p53 protein expression started from 7 h postinduction and was maximal at 24 h (Fig. 1b) .
Human wt p53 strongly inhibits yeast growth on MM
Recombinant strain W303/pDP (negative control) and W303/wt expressing wt p53 were cultured in liquid MM containing 2% galactose (inducing condition) or glucose (repressing condition). In the presence of glucose, the recombinant yeast clones grew at the same rate (Fig. 2a) . Galactose induction of the wt p53 (W303/wt clone) under MM conditions resulted in complete growth inhibition of yeast (Fig. 2b) . In contrast, the growth of the control (W303/ pDP) recombinant yeast was not impaired by galactose and was very similar to that in glucose-containing MM (Fig. 2b) . The p53-induced growth inhibition was confirmed on solid MM plates containing either glucose or galactose (Fig. 2c) . We concluded that p53 expression impaired yeast growth, but we did not know at this point whether the inhibitory effect was due to a functional p53 or just a cytotoxic effect due to the overexpression of an exogenous protein. Therefore, we sought to express the transcriptionally inactive R248W p53 hot spot mutant (Kato et al., 2003) in yeast. Interestingly, the transcriptionally inactive mutant p53 R248W, which was expressed at a similar level as the wt p53 ( Fig. 1c) , had no detectable effect on yeast growth on MM (Fig. 2b and c) . These data suggest that wt p53 exerts an active growth inhibitory effect on yeast, which may be related to its transcriptional activity on selective yeast genes involved in cell cycle arrest or cell death.
To evaluate the relative levels of surviving yeast after wt and mutant p53 induction in MM, the number of cells in each spot from the experiment depicted in Fig. 2c was evaluated by counting CFUs. The percentage of recovered viable cells after p53 gene induction by galactose was calculated. In agreement with the above-described results, the viable cell recovery numbers on solid MM cultures followed the same hierarchy as the growth in galactosecontaining liquid and solid MM, i.e. W303/wt p53 (15.75%), negative control W303/pDP (90.15%) and W303/R248W mutant (87.5%).
In a previous study, we had noticed that the expression of the wt p53 protein under RM conditions led to a growth delay that was more pronounced during the exponential phase (Mokdad-Gargouri et al., 2001) than in the latency and stationary plateau phases. We grew all strains on RM; Fig. 2 shows that the wt p53 protein again led to a slight delay of cell growth but the R248W mutant did not slow down yeast growth in RM, as the control strain (Fig. 2d) . This result further demonstrates the effect of the R248W mutation.
Taken together, these findings suggest that p53 expression and culture on MM were essential to uncover the important biological effects of human p53 in S. cerevisiae.
wt p53 expression induces yeast cell death
The loss of growth and viability of p53-expressing yeast cultures in MM suggested that yeast cells died following p53 gene induction. Because p53 is a potent proapoptotic gene in mammalian cells, and it is now established that yeast cell death can occur by apoptosis (Madeo et al., 1997 (Madeo et al., , 2002 Gourlay et al., 2006) , we asked whether p53-mediated growth inhibition resulted from yeast cell death. Thus, yeast cells expressing the wt p53 protein were grown on raffinosecontaining MM and then induced for 24 h with 2% galactose. Yeast cells were harvested and assayed for two different apoptotic cell death markers. Firstly, exposure of phosphatidylserine at the outer surface of the plasma membrane, an early marker of cell death, was detected by labelling cells with fluorescein-coupled annexin V (green dye). Early apoptotic cells were distinguished from necrotic and late apoptotic cells by their ability to exclude PI (red dye), a membrane-impermeable DNA staining. Figure 3a shows a clear annexin V staining of W303/wt p53 yeast cells, compared with control cells W303/pDP that remained unstained. Interestingly, some Annexin V-positive cells, which were PI negative, should be considered at the beginning of the apoptotic cell death process. PI also clearly stained some annexin V-positive cells, which could be considered to be at the late stage of cell death.
Secondly, DNA fragmentation was detected by the TU-NEL assay. wt p53-expressing cells showed strong staining (Fig. 3b) , indicating the presence of DNA strand breaks whereas control cells (W303/pDP) showed a background staining. Yeast cells treated with DNAse were used as a positive control for the TUNEL assay. These results were further supported by FACS analysis, which revealed 94.4% TUNEL-positive in wt p53-expressing cells and 7% in the control (W303/pDP) cells (Fig. 3c) .
Effect of wt p53 expression on yeast gene transcription
In order to investigate the mechanism of p53-induced cell growth impairment and death in yeast, DD analysis was carried out between W303/wt p53 and control W303/pDP cells. Besides several bands that are equally present in both lines, some mRNAs appeared to be differentially expressed (either increased or decreased) in W303/wt compared with control W303/pDP cells (Fig. 4a) . This finding indicated that the presence of the human p53 transcription factor modified, directly or indirectly, the transcription of several yeast genes either by activation or by repression. Some cDNA fragments have been sequenced and shown to belong to yeast genes. One of the most downregulated genes presented complete identity with yeast thioredoxin TRX2 and 76% identity with TRX1. This result was further supported by Northern blot analysis, using the fragment isolated from DD analysis as a probe. Figure 4b shows that, in the control strain (W303/pDP), two bands are present (the upper one is more intense than the second), which should correspond to the TRX2 and TRX1 mRNA, respectively. Both bands were completely absent in the p53 wt-expressing yeast cells. Our results strongly suggest that wt p53 downregulates yeast thioredoxin (TRX1/2) expression.
p53-expressing yeast cells accumulate ROS
Thioredoxin is a highly conserved multifunctional antioxidative and antiapoptotic protein family. The downregulation of the TRX1/2 yeast genes in p53-expressing yeast cells, , then harvested by centrifugation, washed with distilled water and used to inoculate at 1/1000 the galactose-containing RM. A 600 nm was measured at different time intervals.
as shown by DD and Northern blot, suggested the involvement of ROS in the p53-induced cell death. This hypothesis was directly confirmed using DHR 123, which is oxidized to the fluorescent chromophore rhodamine 123 by ROS. Most of the p53 wt-expressing yeast cells (W303/wt p53) cultured under MM conditions showed strong positive staining whereas the control strain W303/pDP did not show any fluorescence (Fig. 5) .
Discussion
Considering that p53 is an important regulator of cell cycle genes in mammals, inhibition of yeast growth by wt p53 could seem to be an expected result. Yet, only slight growth delays were observed by previous investigators (Nigro et al., 1992; Mokdad-Gargouri et al., 2001) . Moreover, Nigro et al. (1992) had to coexpress the CDC2H gene, a cell cycle negative regulator, together with p53, to see a modest growth inhibition due to a partial arrest in G1. A novel approach in the present study consisted of using a multicopy instead of a centromeric low-copy-number vector. Thus, we suggest that the p53 growth inhibition in yeast could be gene dose dependent.
A second original point was to stress or starve yeast cells using MM culture conditions, thus rendering them more responsive to target gene regulation by p53. It is noteworthy that in mammalian cells deprived of nutrients such as serum or subjected to various stresses (DNA damage, irradiation, oxidative stress, etc.), the p53 activity and the resulting signalling pathways are strongly induced (Prives & Hall, 1999) , leading to cell growth arrest, DNA repair and eventually death by apoptosis (Harris & Levine, 2005) . Similarly, it is possible that yeast growth is subject to limiting factors in MM, making the yeast more sensitive to the induction of 'stress genes' by p53. The reduction of such sensitivity on RM suggests that p53 overexpression and cultures on minimal media were both responsible for this growth inhibition.
Cell growth arrest and apoptosis induced by p53 in mammalian cells has been initially related to its ability to modulate the target gene transcription. R248W is among the most frequent missense mutations associated with cancers. This mutant falls into 'the DNA-contact mutant' class, based on the crystal structure of the DNA-binding domain in complex with the DNA consensus sequence (Bullock & Fersht, 2001) . The R248 codon is highly conserved between species due to its direct binding to DNA target sequences and is thus transcriptionally inactive in the yeast functional assay (FASAY) (Kato et al., 2003) . In agreement with these observations, the present work clearly confirms that this mutation inactivates the p53 protein completely in the yeast context. Its expression did not affect yeast growth either under MM or under RM culture conditions. It is thus likely that, although no p53 orthologue has been identified in yeast as yet, the human p53 may still target some genes (possibly conserved from yeast to humans) involved in cell growth inhibition or cell death. The p53 activation may be conserved in yeast. Indeed, Del Carratore et al. (2004) had demonstrated that p53 Ser 15 was increasingly phosphorylated when p53-expressing yeast cells were treated with increasing doses of UV.
The most striking finding in this study was that wt p53 overexpression in S. cerevisiae induced cell death. Yeast cell death with the characteristic markers of apoptosis such as external-membrane exposure of phosphatidylserine, DNA fragmentation and chromatin condensation was first described in yeast by Madeo et al. (1997) in a cell cycle gene mutant yeast. Some external stresses such as exposure to low doses of H 2 O 2 (Madeo et al., 2002) , acetic acid (Ludovico et al., 2001) or aspirin (Balzan et al., 2004) also induce apoptosis in yeast. The human p53 is the second heterologous proapoptotic gene after bax (Ligr et al., 1998) that induces apoptosis in S. cerevisiae. These findings further suggest the presence of basal apoptosis elements shared between yeast and humans and that p53 should have targets (DNA and/or protein) in the yeast context. p53 plays an important role in regulating apoptosis in mammalian cells through its transcriptional and nontranscriptional activities. Here, we asked whether p53 affects the yeast gene transcription. The DD approach showed clearly that wt p53 disturbed the transcription status of several yeast genes, and Northern blot analysis revealed the absence of TRX1/2 gene expression in wt p53-expressing yeast cells. Thioredoxin reductase (TRR) was shown to be necessary for p53 transcriptional activity. Pearson & Merrill (1998) suggested that p53 can form disulphides that must be reduced for p53 to function as a transcription factor. Moreover, Merrill et al. (1999) showed that oxidative conditions inhibit both DNA binding and transactivation by p53. Here, we show that p53 affected TRX transcription in the yeast context. The transcription of TRX genes might therefore be directly repressed by p53 (transrepression) or indirectly repressed through the interaction of p53 with yeast regulatory proteins.
TRX are small thiol oxidoreductases. Saccharomyces cerevisiae contains two cytosolic (TRX1 and TRX2) and one mitochondrial (TRX3) thioredoxin (Gan, 1991 Masaya et al. (2000) showed that TRX overexpression was associated with p53 mutations in some breast tumours. The yeast model could be exploited to understand the complex relationship between p53-induced apoptosis and TRX expression. So far, yeast was only used as a tool to evaluate the transactivation capacity of p53 tumour mutants through FASAY analysis. The ability of human p53 to induce cell death in the yeast S. cerevisiae could provide a useful tool for investigating other biological functions of human p53 and provide novel insights into the mechanisms of p53-dependent apoptosis. We suggest that mutated forms of p53 isolated from human cancers should be tested in yeast not only through the use of a FASAY system (transcriptional activity) but according to their ability to induce yeast cell death and also to screen for the relationship between the transcriptional and apoptotic activity of p53 mutants.
